MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/tlcr-22-199

Медицинская библиотека · Translational lung cancer research · 2022

Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach.

Klotz Laura V, Hoffmann Hans, Shah Rajiv, Eichhorn Florian, Gruenewald Christiane, Bulut Elena L, Griffo Raffaella, Muley Thomas, Christopoulos Petros, Baum Philip, Huber Peter, Safi Seyer, Kriegsmann Marc, Thomas Michael, Bischoff Helge, Winter Hauke, Eichhorn Martin E

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The exact role and type of surgery for malignant pleural mesothelioma (MPM) remains controversial. This study aimed at analyzing a 20-year single center perioperative experience in MPM surgery at our high-volume thoracic surgery center and comparing the overall survival after trimodal extrapleural pneumonectomy (EPP) and extended pleurectomy and decortication combined with hyperthermic intrathoracic chemoperfusion (EPD/HITOC) and adjuvant chemotherapy with that after chemotherapy (CTx) alone.

METHODS

Patients with epithelioid MPM treated with neoadjuvant chemotherapy, EPP and adjuvant radiotherapy within a trimodal concept or EPD/HITOC in combination with adjuvant chemotherapy between 2001 and 2018 were included in this retrospective analysis. Surgical cohorts were compared to patients treated with standard chemotherapy.

RESULTS

Overall, 182 patients (69 EPP, 57 EPD/HITOC, 56 CTx) were analyzed. Due to occupational exposure to asbestos for most of the patients, 154 patients (84.6%) were male. The patients in the surgical cohorts were significantly younger than those in the CTx cohort. There was no significant difference between the proportion of patient age and side. The median overall survival of the EPD/HITOC cohort with 38.1 months was significantly longer than that of the EPP and CTx cohorts (24.0 and 15.8 months). Better survival was significantly associated with an ECOG 0 performance status, age below 70 years, and negative lymph node status. In the multivariate analysis, EPD/HITOC was significantly associated with improved overall survival. Perioperative morbidity was lower in the EPD/HITOC group than in the EPP cohort.

CONCLUSIONS

EPD/HITOC is feasible and safe for localized epithelioid pleural mesothelioma. Changing the surgical approach to a less radical lung-sparing technique may improve overall survival compared to trimodal EPP.

Для цитирования: Klotz Laura V, Hoffmann Hans, Shah Rajiv, Eichhorn Florian, Gruenewald Christiane, Bulut Elena L, Griffo Raffaella, Muley Thomas, Christopoulos Petros, Baum Philip, Huber Peter, Safi Seyer, Kriegsmann Marc, Thomas Michael, Bischoff Helge, Winter Hauke, Eichhorn Martin E. Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach.. Translational lung cancer research. 2022. DOI: 10.21037/tlcr-22-199.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.